Cytokinetics (CYTK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,515 | 13,061 | 10,278 | N/A | N/A |
| Marketable Securities | 62,697 | 92,637 | 24,197 | N/A | N/A |
| Receivables | 576 | 53 | 263 | N/A | N/A |
| Other current assets | 151 | 713 | 0 | 0 | 0 |
| TOTAL | $78,864 | $109,067 | $37,076 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 6,178 | 7,336 | 8,870 | N/A | N/A |
| Investments And Advances | 0 | 4,555 | 7,857 | 0 | 0 |
| Other Non-Current Assets | 6,419 | 7,143 | 9,070 | 0 | 0 |
| TOTAL | $12,597 | $19,034 | $25,797 | $N/A | $N/A |
| Total Assets | $91,461 | $128,101 | $62,873 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,726 | 2,387 | 2,008 | N/A | N/A |
| Accounts payable and accrued liabilities | 3,001 | 2,155 | 1,589 | 0 | 0 |
| Accrued Expenses | 4,137 | 3,697 | 3,060 | N/A | N/A |
| TOTAL | $11,264 | $11,039 | $9,457 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 6,636 | 8,106 | 8,075 | N/A | N/A |
| Deferred Revenues | 1,400 | 2,800 | 2,800 | N/A | N/A |
| Other Non-Current Liabilities | 0 | 0 | 133,172 | 0 | 0 |
| TOTAL | $6,636 | $9,506 | $145,447 | $N/A | $N/A |
| Total Liabilities | $17,900 | $20,545 | $154,904 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,929 | 4,751 | N/A | N/A | N/A |
| Common Shares | 30 | 28 | 2 | N/A | N/A |
| Retained earnings | -173,524 | -131,272 | -94,074 | N/A | N/A |
| Other shareholders' equity | -2,466 | -4,439 | -3,605 | 0 | 0 |
| TOTAL | $73,561 | $107,556 | $-92,031 | $N/A | $N/A |
| Total Liabilities And Equity | $91,461 | $128,101 | $62,873 | $0 | $0 |